{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:53:15Z","timestamp":1781790795799,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ajo.2025.11.037","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:42:39Z","timestamp":1764290559000},"page":"81-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Atrophy Advisor: A Clinical Tool for Dry Macular Degeneration With Geographic Atrophy"],"prefix":"10.1016","volume":"283","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9170-980X","authenticated-orcid":false,"given":"Avery F.","family":"Kerwin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot M.","family":"Perlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0442-8122","authenticated-orcid":false,"given":"David J.","family":"Browning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajo.2025.11.037_bib0001","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ophtha.2017.08.038","article-title":"The progression of geographic atrophy secondary to age-related macular degeneration","volume":"125","author":"Fleckenstein","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2025.11.037_bib0002","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/OPTH.S226425","article-title":"Burden of illness in geographic atrophy: a study of vision-related quality of life and health care resource use","volume":"14","author":"Patel","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.037_bib0003","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0161-6420(92)31871-8","article-title":"Prevalence of age-related maculopathy. The Beaver Dam Eye Study","volume":"99","author":"Klein","year":"1992","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.037_bib0004","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ophtha.2013.11.023","article-title":"Geographic atrophy: clinical features and potential therapeutic approaches","volume":"121","author":"Holz","year":"2014","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.037_bib0005","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/bjophthalmol-2016-308422","article-title":"Drusen volume development over time and its relevance to the course of age-related macular degeneration","volume":"101","author":"Schlanitz","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.037_bib0006","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/opo.12675","article-title":"Risk factors for progression of age-related macular degeneration","volume":"40","author":"Heesterbeek","year":"2020","journal-title":"Ophthalmic Physiol Opt"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.037_bib0007","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bjo.2005.073643","article-title":"Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation","volume":"90","author":"Khan","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.037_bib0008","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1086\/503822","article-title":"Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration","volume":"78","author":"Schmidt","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.037_bib0009","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ajo.2015.05.009","article-title":"Increased fundus autofluorescence and progression of geographic atrophy secondary to age-related macular degeneration: the GAIN study","volume":"160","author":"Biarn\u00e9s","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.037_bib0010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ophtha.2015.09.036","article-title":"Natural history of geographic atrophy progression secondary to age-related macular degeneration (Geographic Atrophy Progression Study)","volume":"123","author":"Schmitz-Valckenberg","year":"2016","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.037_bib0011","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.ophtha.2018.05.028","article-title":"Progression of geographic atrophy in age-related macular degeneration: AREDS2 report number 16","volume":"125","author":"Keenan","year":"2018","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.037_bib0012","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000361077","article-title":"Geographic atrophy progression in eyes with age-related macular degeneration: role of fundus autofluorescence patterns, fellow eye and baseline atrophy area","volume":"52","author":"Bat\u0131o\u011flu","year":"2014","journal-title":"Ophthalmic Res"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.037_bib0013","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ajo.2006.11.041","article-title":"Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration","volume":"143","author":"Holz","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.037_bib0014","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/eye.2013.275","article-title":"Predictors for the progression of geographic atrophy in patients with age-related macular degeneration: fundus autofluorescence study with modified fundus camera","volume":"28","author":"Jeong","year":"2014","journal-title":"Eye (Lond)"},{"issue":"10411","key":"10.1016\/j.ajo.2025.11.037_bib0015","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","article-title":"Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials","volume":"402","author":"Heier","year":"2023","journal-title":"The Lancet"},{"issue":"10411","key":"10.1016\/j.ajo.2025.11.037_bib0016","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","article-title":"Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial","volume":"402","author":"Khanani","year":"2023","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.037_bib0017","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ophtha.2024.11.017","article-title":"Visual loss in geographic atrophy: learnings from the lampalizumab trials","volume":"132","author":"Anegondi","year":"2025","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.037_bib0018","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Falavarjani","year":"2013","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.037_bib0019","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.oret.2023.08.003","article-title":"A cost-effectiveness analysis of pegcetacoplan for the treatment of geographic atrophy","volume":"8","author":"Patel","year":"2024","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ajo.2025.11.037_bib0020","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ajo.2025.04.022","article-title":"Ocular adverse events associated with pegcetacoplan and avacincaptad pegol for geographic atrophy: a population-based pharmacovigilance study","volume":"276","author":"Kailani","year":"2025","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.037_bib0021","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ophtha.2024.07.014","article-title":"Oral antioxidant and lutein\/zeaxanthin supplements slow geographic atrophy progression to the fovea in age-related macular degeneration","volume":"132","author":"Keenan","year":"2025","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.037_bib0022","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.037_bib0023","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archopht.1990.01070030057028","article-title":"The size and shape of the optic disc in normal human eyes","volume":"108","author":"Quigley","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.037_bib0024","unstructured":"Heidelberg Engineering. SPECTRALIS OCT\u2014the modular imaging platform | Heidelberg Engineering. Accessed 10 October 2025. https:\/\/business-lounge.heidelbergengineering.com\/us\/en\/products\/spectralis\/spectralis\/"},{"key":"10.1016\/j.ajo.2025.11.037_bib0025","unstructured":"ZEISS. ZEISS OCT systems: OCT solutions designed for the way you work. Accessed 10 October 2025. https:\/\/www.zeiss.com\/meditec\/en\/products\/optical-coherence-tomography-devices.html"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.037_bib0026","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.oret.2020.03.020","article-title":"Progression of unifocal versus multifocal geographic atrophy in age-related macular degeneration: a systematic review and meta-analysis","volume":"4","author":"Shen","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ajo.2025.11.037_bib0027","unstructured":"Social Security Administration. Period life table, 2022, as used in the 2025 trustees report. Accessed 10 October 2025. https:\/\/www.ssa.gov\/oact\/STATS\/table4c6.html"},{"key":"10.1016\/j.ajo.2025.11.037_bib0028","unstructured":"University of Connecticut Goldenson Center. Healthy life expectancy calculator. 2025. Accessed 10 October 2025. https:\/\/apps.goldensoncenter.uconn.edu\/HLEC\/"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.037_bib0029","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ophtha.2016.09.012","article-title":"Incidence and growth of geographic atrophy during 5 years of comparison of age-related macular degeneration treatments trials","volume":"124","author":"Grunwald","year":"2017","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.037_bib0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.oret.2022.08.003","article-title":"Predicting topographic disease progression and treatment response of pegcetacoplan in geographic atrophy quantified by deep learning","volume":"7","author":"Vogl","year":"2023","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.037_bib0031","first-page":"2","article-title":"Topographic variation of the growth rate of geographic atrophy in nonexudative age-related macular degeneration: a systematic review and meta-analysis","volume":"61","author":"Shen","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.037_bib0032","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ophtha.2011.09.027","article-title":"Age and gender variations in Age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis","volume":"119","author":"Rudnicka","year":"2012","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.037_bib0033","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/aos.15767","article-title":"Epidemiology of geographic atrophy and its precursor features of intermediate age-related macular degeneration","volume":"101","author":"Vujosevic","year":"2023","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.037_bib0034","article-title":"Smoking and age-related macular degeneration: review and update","volume":"2013","author":"Velilla","year":"2013","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.037_bib0035","unstructured":"American Lung Association. Tobacco Trends Brief: Overall Tobacco Trends Brief. American Lung Association. Accessed 10 October 2025. https:\/\/www.lung.org\/research\/trends-in-lung-disease\/tobacco-trends-brief\/overall-smoking-trends"},{"issue":"5-a suppl","key":"10.1016\/j.ajo.2025.11.037_bib0036","first-page":"S2","article-title":"Geographic atrophy: mechanism of disease, pathophysiology, and role of the complement system","volume":"29","author":"Bakri","year":"2023","journal-title":"J Manag Care Spec Pharm"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.037_bib0037","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/IAE.0000000000003796","article-title":"Complement inhibition for geographic atrophy: review of salient functional outcomes and perspective","volume":"43","author":"Spaide","year":"2023","journal-title":"Retina"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.037_bib0038","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1016\/j.ophtha.2013.07.047","article-title":"Circularity index as a risk factor for progression of geographic atrophy","volume":"120","author":"Domalpally","year":"2013","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.037_bib0039","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamaophthalmol.2018.1544","article-title":"Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: chroma and Spectri phase 3 randomized clinical trials","volume":"136","author":"Holz","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.037_bib0040","doi-asserted-by":"crossref","first-page":"7362","DOI":"10.1167\/iovs.12-11073","article-title":"Association between geographic atrophy progression and reticular pseudodrusen in eyes with dry age-related macular degeneration","volume":"54","author":"Marsiglia","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.037_bib0041","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/eye.2010.133","article-title":"The relationship between visual field loss in glaucoma and health-related quality-of-life","volume":"24","author":"van Gestel","year":"2010","journal-title":"Eye (Lond)"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.037_bib0042","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1007\/s00417-021-05145-9","article-title":"Geographic atrophy severity and mortality in age-related macular degeneration","volume":"259","author":"Ahluwalia","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.037_bib0043","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.oret.2020.04.014","article-title":"Genotype- and phenotype-based subgroups in geographic atrophy secondary to age-related macular degeneration: the EYE-RISK consortium","volume":"4","author":"Biarn\u00e9s","year":"2020","journal-title":"Ophthalmol Retina"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.037_bib0044","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ng.3448","article-title":"A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants","volume":"48","author":"Fritsche","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajo.2025.11.037_bib0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2415-10-31","article-title":"Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis","volume":"10","author":"Chakravarthy","year":"2010","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.037_bib0046","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.survophthal.2019.01.014","article-title":"Microperimetry for geographic atrophy secondary to age-related macular degeneration","volume":"64","author":"Csaky","year":"2019","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.037_bib0047","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1177\/11206721241287252","article-title":"Geographic atrophy progression secondary to age-related macular degeneration: five years of follow-up","volume":"35","author":"Sadeghi","year":"2025","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.037_bib0048","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1167\/tvst.7.6.40","article-title":"The rate of progression of geographic atrophy decreases with increasing baseline lesion size even after the square root transformation","volume":"7","author":"Mon\u00e9s","year":"2018","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.037_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2024.100635","article-title":"Deep learning to predict the future growth of geographic atrophy from fundus autofluorescence","volume":"5","author":"Salvi","year":"2025","journal-title":"Ophthalmol Sci"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.037_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jpm13010037","article-title":"Machine learning-based automated detection and quantification of geographic atrophy and hypertransmission defects using spectral domain optical coherence tomography","volume":"13","author":"Kalra","year":"2022","journal-title":"J Pers Med"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.037_bib0051","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.xops.2024.100466","article-title":"Deep learning-based prediction of individual geographic atrophy progression from a single baseline OCT","volume":"4","author":"Mai","year":"2024","journal-title":"Ophthalmol Sci"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425006361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425006361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:15:32Z","timestamp":1781788532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939425006361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":51,"alternative-id":["S0002939425006361"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2025.11.037","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrophy Advisor: A Clinical Tool for Dry Macular Degeneration With Geographic Atrophy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2025.11.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}